Asian Spectator


The Times

.

Mangroves Documentary Premieres, Exploring How Cities and Wetlands Coexist

SHENZHEN, CHINA – Media OutReach Newswire – 17 November 2026 – Guangdong Radio and Television has unveiled Mangroves, a three-part ecological documentary filmed in 4K ultra-high de...

Juungar Banner: Building a Reserve of Seed Crabs on Saline-Alkali Flats

ORDOS, CHINA – Media OutReach Newswire – 29 October 2026 – Recently, 20,000-plus jin, or roughly 10 metric tons, of seed crabs raised in-house at the Yellow River Rice-Fis...

CHINAPLAS 2026: Quality Growth Driven by Technology, Thriving Future Powered by Green Solutions

SHANGHAI, CHINA - Media OutReach Newswire - 17 November 2025 –On April 21 to 24, 2026, the industry's acclaimed trade fair - CHINAPLAS 2026 will take place at National Exhibition and ...

Amari Vientiane: Experience the Charm of a Cultural Gem on the Mekong River in the Heart of Laos

BANGKOK, THAILAND - Media OutReach Newswire - 28 February 2025 - ONYX Hospitality Group, a leading management company in Southeast Asia, specialising in hotels, resorts, serviced apartment...

Aspire Integrates with Stripe to Help Businesses Get Paid 2x Faster

Aspire users can now offer credit card payments for invoices and through payment links, providing greater flexibility, ease and convenience to their customers. SINGAPORE - Media OutReach Ne...

Airbiquity Expands Into Additional Markets that Require Indust...

SEATTLE, July 20, 2021 /PRNewswire-AsiaNet/ -- -- Airbiquity to provide higher degrees of OTA management, security, and technical integration for multiple non-automotive vehicle-based market...

Researchers probe the potential impact of medicinal cannabis o...

SYDNEY, Jan. 20, 2022 /PRNewswire-AsiaNet/ -- - Long COVID refers to the chronic symptoms of COVID-19, which include chronicpain, sleep disturbances and fatigue - The Bod Australia study, in...

FinTech Olympiad Competition: Registration is Now Open Encouraging Tertiary Students to Propose FinTech-enabled Social Innovations that Help Solve Real-World Problems

HONG KONG SAR - Media OutReach - 22 February 2023 - The FinTech Olympiad (FTOL) 2023 hosted by City University of Hong Kong (CityU) and supported by HSBC now calls for entries to the final ...

Over 3500 Participants Gather at the Digital Entertainment Leadership Forum 2024 (DELF 2024)

More than 60 Expert Speakers Explore the Innovative Future of AI Driven Entertainment IndustryHONG KONG SAR - Media OutReach Newswire - 19 August 2024 - The annual Digital Entertainment ...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegaluk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet girisStreamEastStreamEastjojobet